July 21, 2011 -- The ChinaBio® Investor Forum–Jinan chose two early stage life science companies as the “Most Promising” of the 17 presenting companies at the recently held conference. Cardeus Pharmaceuticals was selected in the pharmaceutical category, and Beijing UniMedex was named in the devices and services group. The ChinaBio event brought together more than 180 attendees, including international VCs and investors from China, the US, and Japan. A panel of VCs and pharma executives selected the two companies for the "Most Promising" honor based on their especially compelling business plans. More details....
